12 Nov 2026

Hot Topics in HIV – Vaccines, immune recovery and eradication 2026

HIV
On-site
English
Casa Seat, Barcelona

Status

Available

Price

Free

Enter and register!

The conference is addressed to researchers and physicians specialized in HIV.

Information

After more than four decades of HIV research, prevention and antiretroviral therapy have significantly reduced transmission and improved life expectancy. However, these advances have not been sufficient to end the epidemic. Current research therefore focuses on cure strategies aimed at eliminating the viral reservoir or achieving long-term, treatment-free viral remission.

This annual meeting highlights the latest advances in HIV research, with a strong focus on novel immunotherapies, viral reservoir reduction, latency and reactivation mechanisms, and innovative cell- and gene-based cure strategies. The conference brings together experts and young investigators to explore paths toward long-term, treatment-free HIV control.

Coordinators

Javier Martínez – Picado

Researcher and professor

ICREA, Irsicaixa AIDS Research Institute, Barcelona, Spain

Javier Martínez – Picado

Researcher and professor

ICREA Research Professor and Principal Investigator at Retrovirology and Clinical Studies research group, Irsicaixa AIDS Research Institute, Barcelona, Spain.

View more
Bonaventura Clotet

President of Fundació Lluita contra les Infeccions and Director of IrsiCaixa

Fundació Lluita contra les Infeccions, IrsiCaixa AIDS Research Institute and Catalan Health Institute, Badalona, Spain.

Bonaventura Clotet

President of Fundació Lluita contra les Infeccions and Director of IrsiCaixa

Dr. Clotet received his MD (1976) and his PhD (1981), with a thesis on autoimmune diseases, from the Autonomous University of Barcelona (UAB). That same year, his internship as an Internal Medicine specialist at the Vall d’Hebron University Hospital in Barcelona coincided with the first AIDS case reported in Spain. This case was the catalyst for a career dedicated to this serious disease, first as head of the HIV Unit of the Germans Trias i Pujol University Hospital in Badalona (1987-2015) and then as founder and president of the Fight against AIDS Foundation (1992), which is now named as Fight Infections Foundation.

Dr. Clotet soon saw the need to go a step beyond patient care to conduct research aimed at eradicating AIDS. In 1995, with the support of “la Caixa” and the Department of Health of the Generalitat of Catalonia, he founded the IrsiCaixa AIDS Research Institute, which he still heads. In addition, Dr. Clotet is also the clinical director of Infectious Diseases at the Metropolitana Nord area of the Catalan Institute of Health, scientific advisor to two IrsiCaixa spin-offs: Aelix Therapeutics SL and AlbaJuna Therapeutics SL and director of the Chair of AIDS and Related Diseases at the Universitat de Vic (UVic).

He has published more than 1000 papers in high impact international journals and his contributions to research have been recognized with the Josep Trueta medal to Sanitary Merit and the ‘Premi Nacional de Recerca’, among other awards.

View more